Trial Profile
Rollover Study of Weekly Paclitaxel (BMS-181339) in Patients With Head and Neck Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Apr 2022
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary)
- Indications Head and neck cancer
- Focus Adverse reactions
- Sponsors Bristol-Myers Squibb
- 23 Mar 2017 New trial record